tiprankstipranks
Top Stocks
U.S. Stock Market OverviewTop Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
Top ETFs by AUMSPY ETFQQQ ETF
Stock Comparison
Energy StocksOil StocksBest Value StocksAirline StocksElectric Vehicle StocksMATANA Stocks
New
Bank StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
Global Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsPre-Market BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsTools for Trading PlatformsData for Hedge FundsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Top ETFs by AUM
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
U.S. Markets
Market Movers
Expert Center
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
Top ETFs by AUM
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Energy Stocks
EV Stocks
Crypto News
Dividend Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Pre-Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

THTX Stock Latest News

Theratechnologies focused on achieving positive EBITDA in the near-term
The FlyTheratechnologies focused on achieving positive EBITDA in the near-term
27d ago
THTX
Theratechnologies forms committee for Protocol Amendment for TH1902 trial
The FlyTheratechnologies forms committee for Protocol Amendment for TH1902 trial
27d ago
THTX
Theratechnologies CEO says positioned ‘product portfolio for commercial success’
The FlyTheratechnologies CEO says positioned ‘product portfolio for commercial success’
27d ago
THTX
Theratechnologies sees 2023 revenue $90M-$95M, consensus $95.44M
The FlyTheratechnologies sees 2023 revenue $90M-$95M, consensus $95.44M
27d ago
THTX
Open Letter to Shareholders from CEO Paul Levesque
Press ReleasesOpen Letter to Shareholders from CEO Paul Levesque
27d ago
THTX
Theratechnologies sees 2022 revenue $80M, consensus $79.38M
The FlyTheratechnologies sees 2022 revenue $80M, consensus $79.38M
27d ago
THTX
Theratechnologies Nosedives on Pausing Phase 1 Trial
Market NewsTheratechnologies Nosedives on Pausing Phase 1 Trial
2M ago
THTX
Theratechnologies Announces Update from Ongoing TH1902 Study
Press ReleasesTheratechnologies Announces Update from Ongoing TH1902 Study
2M ago
THTX
Theratechnologies announces update from TH1902 study
The FlyTheratechnologies announces update from TH1902 study
2M ago
THTX
Theratechnologies initiated with a Buy at JonesTrading
The FlyTheratechnologies initiated with a Buy at JonesTrading
2M ago
THTX
Theratechnologies’ Trogarzo® Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily Treatment-Experienced Population
Press ReleasesTheratechnologies’ Trogarzo® Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily Treatment-Experienced Population
4M ago
THTX
Theratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Update
Press ReleasesTheratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Update
4M ago
THTX
Theratechnologies to Present at the Cantor Oncology, Hematology & HemeOnc Conference
Press ReleasesTheratechnologies to Present at the Cantor Oncology, Hematology & HemeOnc Conference
4M ago
THTX
Theratechnologies TH1902 Study Published in Pharmaceutics Demonstrates Inhibition of Human Sortilin (SORT1)-Positive Ovarian and Triple-Negative Breast Cancer Stem-Like Cells and Tumor Growth
Press ReleasesTheratechnologies TH1902 Study Published in Pharmaceutics Demonstrates Inhibition of Human Sortilin (SORT1)-Positive Ovarian and Triple-Negative Breast Cancer Stem-Like Cells and Tumor Growth
5M ago
THTX
Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Credit Agreement
Press ReleasesTheratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Credit Agreement
6M ago
THTX
Theratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results and Provides Business Update
Press ReleasesTheratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results and Provides Business Update
7M ago
THTX
Theratechnologies Provides Update on the Dose Escalation Portion of Fast Track Designated TH1902 First-in-Human Study in Advanced Resistant Malignancies
Press ReleasesTheratechnologies Provides Update on the Dose Escalation Portion of Fast Track Designated TH1902 First-in-Human Study in Advanced Resistant Malignancies
7M ago
THTX
Theratechnologies Announces Binding Commitment for a Non-Dilutive Term Loan of up to $100 million from Marathon Asset Management
Press ReleasesTheratechnologies Announces Binding Commitment for a Non-Dilutive Term Loan of up to $100 million from Marathon Asset Management
7M ago
THTX
CQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 million for research project to validate the anti-metastatic potential of TH1902 at the Université du Québec à Montréal
Press ReleasesCQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 million for research project to validate the anti-metastatic potential of TH1902 at the Université du Québec à Montréal
7M ago
THTX
Theratechnologies Announces New Head of Investor Relations
Press ReleasesTheratechnologies Announces New Head of Investor Relations
8M ago
THTX